b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="vetres" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2826090/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Attenuated Salmonella choleraesuis-mediated RNAi targeted to conserved regions against foot-and-mouth disease virus in guinea pigs and swine</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826090/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Veterinary Research" /><meta name="citation_title" content="Attenuated Salmonella choleraesuis-mediated RNAi targeted to conserved regions against foot-and-mouth disease virus in guinea pigs and swine" /><meta name="citation_authors" content="Wei Cong, Hong Jin, Chengda Jiang, Weiyao Yan, Mingqiu Liu, Jiulian Chen, Xiaoping Zuo, Zhaoxin Zheng" /><meta name="citation_date" content="May-Jun 2010" /><meta name="citation_issue" content="3" /><meta name="citation_volume" content="41" /><meta name="citation_doi" content="10.1051/vetres/2010002" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2826090/?report=abstract" /><meta name="citation_pmid" content="20167192" /><meta name="DC.Title" content="Attenuated Salmonella choleraesuis-mediated RNAi targeted to conserved regions against foot-and-mouth disease virus in guinea pigs and swine" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="BioMed Central" /><meta name="DC.Contributor" content="Wei Cong" /><meta name="DC.Contributor" content="Hong Jin" /><meta name="DC.Contributor" content="Chengda Jiang" /><meta name="DC.Contributor" content="Weiyao Yan" /><meta name="DC.Contributor" content="Mingqiu Liu" /><meta name="DC.Contributor" content="Jiulian Chen" /><meta name="DC.Contributor" content="Xiaoping Zuo" /><meta name="DC.Contributor" content="Zhaoxin Zheng" /><meta name="DC.Date" content="May-Jun 2010" /><meta name="DC.Identifier" content="10.1051/vetres/2010002" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Attenuated Salmonella choleraesuis-mediated RNAi targeted to conserved regions against foot-and-mouth disease virus in guinea pigs and swine" /><meta property="og:type" content="article" /><meta property="og:description" content="In this study, specific sequences within three genes (3D, VP4 and 2B) of the foot-and-mouth disease virus (FMDV) genome were determined to be effective RNAi targets. These sequences are highly conserved among different serotype viruses based on sequence ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826090/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-vetres.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2826090/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2826090/pdf/vetres-41-30.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1BEBFCE9A484F100000000017D017D.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/892/">Vet Res</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/184828/">v.41(3); May-Jun 2010</a></li><li class="accid">PMC2826090</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-vetres.png" alt="Logo of vetres" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher\'s site" title="Link to Publisher\'s site" shape="default" coords="0,0,499,74" href="https://veterinaryresearch.biomedcentral.com/" target="pmc_ext" ref="reftype=publisher&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">Vet Res</span>. 2010 May-Jun; 41(3): 30. </span></div><div><span class="fm-vol-iss-date">Published online 2010 Jan 13. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1051%2Fvetres%2F2010002" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1051/vetres/2010002</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2826090</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/20167192">20167192</a></div></div></div></div><h1 class="content-title">Attenuated <em>Salmonella choleraesuis</em>-mediated RNAi targeted to conserved regions against foot-and-mouth disease virus in guinea pigs and swine</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Cong%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20167192" class="affpopup" co-rid="_co_idm140292933694624" co-class="co-affbox">Wei Cong</a>,<sup>1</sup> <a href="/pubmed/?term=Jin%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20167192" class="affpopup" co-rid="_co_idm140292928708640" co-class="co-affbox">Hong Jin</a>,<sup>1</sup> <a href="/pubmed/?term=Jiang%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20167192" class="affpopup" co-rid="_co_idm140292934830560" co-class="co-affbox">Chengda Jiang</a>,<sup>1</sup> <a href="/pubmed/?term=Yan%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20167192" class="affpopup" co-rid="_co_idm140292920995088" co-class="co-affbox">Weiyao Yan</a>,<sup>1</sup> <a href="/pubmed/?term=Liu%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20167192" class="affpopup" co-rid="_co_idm140293019764112" co-class="co-affbox">Mingqiu Liu</a>,<sup>1</sup> <a href="/pubmed/?term=Chen%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20167192" class="affpopup" co-rid="_co_idm140292933787056" co-class="co-affbox">Jiulian Chen</a>,<sup>2</sup> <a href="/pubmed/?term=Zuo%20X%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20167192" class="affpopup" co-rid="_co_idm140292933323552" co-class="co-affbox">Xiaoping Zuo</a>,<sup>2</sup> and  <a href="/pubmed/?term=Zheng%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20167192" class="affpopup" co-rid="_co_idm140292926807712" co-class="co-affbox">Zhaoxin Zheng</a><sup>1,</sup><sup>*</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140292933694624"><h3 class="no_margin">Wei Cong</h3><p><sup>1</sup>\nState Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University 220 Handan Rd. Shanghai\n200433 People&#x02019;s Republic of China</p><div>Find articles by <a href="/pubmed/?term=Cong%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20167192">Wei Cong</a></div></div><div id="_co_idm140292928708640"><h3 class="no_margin">Hong Jin</h3><p><sup>1</sup>\nState Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University 220 Handan Rd. Shanghai\n200433 People&#x02019;s Republic of China</p><div>Find articles by <a href="/pubmed/?term=Jin%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20167192">Hong Jin</a></div></div><div id="_co_idm140292934830560"><h3 class="no_margin">Chengda Jiang</h3><p><sup>1</sup>\nState Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University 220 Handan Rd. Shanghai\n200433 People&#x02019;s Republic of China</p><div>Find articles by <a href="/pubmed/?term=Jiang%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20167192">Chengda Jiang</a></div></div><div id="_co_idm140292920995088"><h3 class="no_margin">Weiyao Yan</h3><p><sup>1</sup>\nState Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University 220 Handan Rd. Shanghai\n200433 People&#x02019;s Republic of China</p><div>Find articles by <a href="/pubmed/?term=Yan%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20167192">Weiyao Yan</a></div></div><div id="_co_idm140293019764112"><h3 class="no_margin">Mingqiu Liu</h3><p><sup>1</sup>\nState Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University 220 Handan Rd. Shanghai\n200433 People&#x02019;s Republic of China</p><div>Find articles by <a href="/pubmed/?term=Liu%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20167192">Mingqiu Liu</a></div></div><div id="_co_idm140292933787056"><h3 class="no_margin">Jiulian Chen</h3><p><sup>2</sup>\nBio-pharmacy, Jinyu Group Co., Ltd. Inner Mongolia\n010020 People&#x02019;s Republic of China</p><div>Find articles by <a href="/pubmed/?term=Chen%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20167192">Jiulian Chen</a></div></div><div id="_co_idm140292933323552"><h3 class="no_margin">Xiaoping Zuo</h3><p><sup>2</sup>\nBio-pharmacy, Jinyu Group Co., Ltd. Inner Mongolia\n010020 People&#x02019;s Republic of China</p><div>Find articles by <a href="/pubmed/?term=Zuo%20X%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20167192">Xiaoping Zuo</a></div></div><div id="_co_idm140292926807712"><h3 class="no_margin">Zhaoxin Zheng</h3><p><sup>1</sup>\nState Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University 220 Handan Rd. Shanghai\n200433 People&#x02019;s Republic of China</p><div>Find articles by <a href="/pubmed/?term=Zheng%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20167192">Zhaoxin Zheng</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140292946581824_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140292946581824_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140292946581824_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140292946581824_ai" style="display:none"><div class="fm-affl" lang="en" id="AFF1"><sup>1</sup>\nState Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University 220 Handan Rd. Shanghai\n200433 People&#x02019;s Republic of China</div><div class="fm-affl" lang="en" id="AFF2"><sup>2</sup>\nBio-pharmacy, Jinyu Group Co., Ltd. Inner Mongolia\n010020 People&#x02019;s Republic of China</div><div id="FN1"><sup>*</sup>Corresponding author: <a href="mailto:dev@null" data-email="nc.ude.naduf@gnehzxz" class="oemail">nc.ude.naduf@gnehzxz</a></div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140292946581824_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2009 Apr 21; Accepted 2010 Jan 11.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140292946581824_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; INRA, EDP Sciences, 2010</div><div class="license half_rhythm">This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial License (<a href="http://creativecommons.org/licenses/by-nc/3.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by-nc/3.0/</a>), which permits unrestricted use, distribution, and reproduction in any noncommercial medium, provided the original work is properly cited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2826090/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm140292934164800" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140292934164800title">Abstract</h2><!--article-meta--><div><p id="__p1" class="p p-first-last">In this study, specific sequences within three genes (3D, VP4 and 2B) of the foot-and-mouth disease virus (FMDV) genome were determined to be effective RNAi targets. These sequences are highly conserved among different serotype viruses based on sequence analysis. Small interfering RNA (siRNA)-expressing plasmids (p3D-NT19, p3D-NT56, pVP4-NT19, pVP4-NT65 and p2B-NT25) were constructed to express siRNA targeting 3D, VP4 and 2B, respectively. The antiviral potential of these siRNA for various FMDV isolates was investigated in baby hamster kidney (BHK-21) cells and suckling mice. The results show that these siRNA inhibited virus yield 10- to 300-fold for different FMDV isolates of serotype O and serotype Asia I at 48&#x000a0;h post infection in BHK-21 cells compared to control cells. In suckling mice, p3D-NT56 and p2B-NT25 delayed the death of mice. Twenty percent to 40% of the animals that received a single siRNA dose survived 5 days post infection with serotype O or serotype Asia I. We used an attenuated <em>Salmonella choleraesuis</em> (C500) vaccine strain, to carry the plasmid that expresses siRNA directed against the polymerase gene 3D (p3D-NT56) of FMDV. We used guinea pigs to evaluate the inhibitory effects of recombinant <em>S</em>. <em>cho</em> (p3D-NT56/<em>S</em>. <em>cho</em>) on FMDV infection. The results show that 80% of guinea pigs inoculated with 10<sup>9</sup>&#x000a0;CFU of p3D-NT56/<em>S</em>. <em>cho</em> and challenged 36&#x000a0;h later with 50 ID<sub>50</sub> of homologous FMDV were protected. We also measured the antiviral activity of p3D-NT56/<em>S</em>. <em>cho</em> in swine. The results indicate that 100% of the animals treated with 5&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup>&#x000a0;CFU of p3D-NT56/<em>S</em>. <em>cho</em> were protected in 9 days.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">foot-and-mouth disease virus, RNA interference, <em>Salmonella choleraesuis</em>, conserved sequence, swine</span></div></div><div id="S1" class="tsec sec"><h2 class="head no_bottom_margin" id="S1title">1.\xe2\x80\x83INTRODUCTION</h2><p id="__p2" class="p p-first">Short interfering RNA (siRNA) are small, double-stranded RNA molecules that direct the degradation of complementary messenger RNA via a cellular process known as RNA interference. It is widely believed that RNA interference is an evolutionarily conserved mechanism within eukaryotes and that its functions include endogenous gene regulation, viral defense and the maintenance of genomic stability [<a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832962">14</a>]. Because of the rapidity and specificity of RNAi, this technology could complement and improve the traditional tools available to control important animal pathogens.</p><p id="__p3">Foot-and-mouth disease (FMD) is an extremely contagious disease that affects more than 33 species of cloven-hoofed animals including cattle, swine, and other livestock [<a href="#R36" rid="R36" class=" bibr popnode">36</a>]. The disease has been known for five centuries and its causative agent, the FMD virus (FMDV), belongs to the genus <em>Aphthovirus</em> of the family <em>Picornaviridae</em> [<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832979">1</a>]. The FMDV genome is composed of a positive-sense, single-stranded RNA molecule of about 8500 nucleotides that contains a unique open reading frame. Like other RNA viruses, FMDV is antigenically variable and undergoes rapid mutation. There are seven distinguishable serological types of FMDV, namely O, A, C, Asia I, SAT1, SAT2, and SAT3. Current FMD vaccines based on inactivated virus are effective in preventing the disease, but carry the risks of incomplete inactivation and viral escape from vaccine production laboratories [<a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832985">26</a>], and they fail to induce an immune response in a short period. Thus, the development of emergency antiviral strategies is necessary in order to stem outbreaks of FMD.</p><p id="__p4">As an antiviral technology, RNAi has already been widely researched for use with FMDV [<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832964">5</a>, <a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832967">24</a>, <a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832934">33</a>]. However, establishing RNAi as a viable approach to prevent FMDV requires resolving at least one major issue [<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832981">17</a>, <a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832958">20</a>]: the high genetic variability of FMD viruses. RNAi directed toward specific gene sequences of certain FMDV strains may face risks, especially in the event of an emergent FMD outbreak, because no information about the serotype or genotype of the isolated pathogen would be available while early protection is needed. Therefore, it may be necessary to design several siRNA that focus on the conserved regions of the viral genome [<a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832965">16</a>, <a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832938">17</a>, <a href="#R42" rid="R42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832946">42</a>, <a href="#R46" rid="R46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832974">46</a>]. Previously, we showed that siRNA generated in vitro can effectively inhibit the replication of FMDV in either a specific or cross-inhibitory manner [<a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832984">28</a>]. Another crucial issue that needs to be addressed is the optimal vector for delivery of siRNA-expressing cassettes. Chen et&#x000a0;al. [<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832945">6</a>] demonstrated that treatment with recombinant, replication-defective human adenovirus type 5 expressing short-hairpin RNA significantly reduces the susceptibility of guinea pigs and swine to FMDV infection. However, adenovirus VA1 non-coding RNA is able to inhibit the biogenesis of siRNA and microRNA [<a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832988">30</a>]. This finding suggests that novel siRNA delivery systems would be necessary.</p><p id="__p5">Salmonella, a member of enteric bacilli, is one of the most severe etiological agents of food-borne diseases. It is widely accepted that recombinant live vaccines using attenuated Salmonella as a vector to deliver passenger antigen induce immune responses not only against salmonella infection, but also against passenger pathogenic infection [<a href="#R8" rid="R8" class=" bibr popnode">8</a>]. Live-attenuated <em>Salmonella</em> has been shown to deliver DNA vaccines [<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832952">9</a>, <a href="#R35" rid="R35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832983">35</a>, <a href="#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832972">41</a>, <a href="#R47" rid="R47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832935">47</a>]. Early in the 1970s, Fang et al. screened out an attenuated <em>Salmonella choleraesuis</em> C500, which was a licensed live vaccine against swine paratyphoid [<a href="#R13" rid="R13" class=" bibr popnode">13</a>]. Liu et al. proved that the attenuated <em>S</em>. <em>choleraesuis</em> C500 carrying an oral DNA vaccine induced an immune response against FMDV [<a href="#R29" rid="R29" class=" bibr popnode">29</a>].</p><p id="__p6" class="p p-last">In the present study, we constructed several siRNA-expressing plasmids targeted to conserved sequences within the coding regions of viral polymerase protein 3D, capsid protein VP4 and nonstructural (NP) protein 2B of the FMDV genome. Some of the plasmids inhibited several isolates of serotype O and serotype Asia I FMDV in baby hamster kidney (BHK-21) cells and suckling mice. Furthermore, we reported that siRNA directed against the polymerase protein 3D of FMDV and delivered by attenuated <em>S</em>. <em>choleraesuis</em> were capable of inhibiting virus replication in guinea pigs and swine.</p></div><div id="S2" class="tsec sec"><h2 class="head no_bottom_margin" id="S2title">2.\xe2\x80\x83MATERIALS AND METHODS</h2><div id="S3" class="sec sec-first"><h3 id="S3title">2.1. Bacteria and plasmids</h3><p id="__p7" class="p p-first-last">The attenuated vaccine strain <em>S</em>. <em>choleraesuis</em> C500 was obtained from Nanjing Biological Pharmaceutical Co., Ltd. Attenuated <em>Salmonella typhimurium</em> LB5010 was kindly provided by Prof. Aoquan Wang (Institute of Microbiology, Chinese Academy of Sciences). The plasmid pU6, which has the mouse U6 promoter (P<sub>U6</sub>), was constructed and maintained in our laboratory.</p></div><div id="S4" class="sec"><h3 id="S4title">2.2. Animals</h3><p id="__p8" class="p p-first-last">Suckling mice (C57BL/6), 2 to 3 days old and weighing 3 to 4&#x000a0;g, were maintained by Bio-pharmacy, Jinyu Group Co., Ltd. Male and female guinea pigs weighing 250 to 300&#x000a0;g and large white swine, 2- to 3-months-old and weighing 40 to 50&#x000a0;kg, were used to perform viral challenge. All of the animals were housed in disease-secure isolation facilities in an FMDV-free area, and had no previous FMD contact as confirmed by the absence of detectable anti-FMDV antibodies in their sera.</p></div><div id="S5" class="sec"><h3 id="S5title">2.3. Cells and viruses</h3><p id="__p9" class="p p-first">Human kidney cells (AD-293) were used to grow recombinant replication-defective human adenoviruses (rAd5) and determine virus titers. BHK-21 cells were used to grow FMDV and determine virus infectivity. Both of the cell lines were cultured in Dulbecco&#x02019;s modified Eagle&#x02019;s medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (pH 7.4). Cultures were incubated at 37&#x000a0;&#x000b0;C with 5% CO<sub>2</sub>. Two FMDV isolates of serotype O (HKN/2002 (GenBank accession number <a id="__tag_599417138" class="tag_hotlink" href="/nuccore/AY317098" ref="/nuccore/AY317098"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY317098","term_id":"33348772","term_text":"AY317098"}}</span>AY317098</a>) and CHA/99 (GenBank accession number <a id="__tag_599417136" class="tag_hotlink" href="/nuccore/AJ539138" ref="/nuccore/AJ539138"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AJ539138","term_id":"30145776","term_text":"AJ539138"}}</span>AJ539138</a>)) and two FMDV isolates of serotype Asia I (YNBS/58 (GenBank accession number <a id="__tag_599417135" class="tag_hotlink" href="/nuccore/AY390432" ref="/nuccore/AY390432"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY390432","term_id":"37223495","term_text":"AY390432"}}</span>AY390432</a>) and Jiangsu/2005 (GenBank accession number <a id="__tag_599417137" class="tag_hotlink" href="/nuccore/EF149009" ref="/nuccore/EF149009"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"EF149009","term_id":"122056477","term_text":"EF149009"}}</span>EF149009</a>)) were used for viral challenge.</p><p id="__p10" class="p p-last">Recombinant replication-defective human adenoviruses (Ad5-POL and Ad5-LacZ) were constructed and maintained in our laboratory [<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832989">6</a>]. Ad5-POL expressed siRNA targeting the FMDV 3D sequence corresponding to nucleotides (nt) 1225&#x02013;1280 of HNK/2002 3D. As a control for nonspecific effects of rAd5, Ad5-LacZ expressed siRNA corresponding to nt 1353 to 1435 of the &#x003b2;-galactosidase gene of <em>Escherichia coli</em>, which has no homology to the HKN/2002 genome as confirmed by sequence analysis. The sequence of Ad5-POL encoding the FMDV 3D-specific siRNA was 5&#x02032;-GAGGCTATCCTCTCCTTTGCACGCCGTGGGACCATACAGGAGAAGTTGATCTCCGT-3&#x02032; (sense), and that of Ad5-LacZ encoding the <em>E</em>. <em>coli</em> &#x003b2;-galactosidase-specific siRNA was 5&#x02032;-GAGTGTGATCATCTGGTCGCTGGGGAATGAATCAGGCCACGGCGCTAATCACGACGCGCTGTATCGCTG GATCAAATCTGTCG-3&#x02032; (sense).</p></div><div id="S6" class="sec"><h3 id="S6title">2.4. Construction of siRNA-expressing plasmids</h3><p id="__p11" class="p p-first">As a general strategy for constructing siRNA-expressing plasmids, inverted repeats targeting the sequence were cloned into plasmid pU6&#x000a0;at the EcoRI/HindIII sites, under the control of the U6 promoter and the termination signals of 4 or 5 thymidines. Plasmids p3D-NT19, p3D-NT56, pVP4-NT19, pVP4-NT65 and p2B-NT25 contained inverted repeats corresponding to the nucleotide sequences of the FMDV genome, as described below. As negative controls for nonspecific effects, plasmid pNTH21 and pLacZ contained inverted repeats of 21&#x000a0;nt and 83&#x000a0;nt, respectively, which have no homology to the FMDV genome, as confirmed by sequence analysis.</p><p id="__p12" class="p p-last">The targets of interest were essential during the life cycle of FMDV and relatively conserved in their nucleotide sequences. The reference sequences of the conserved regions of the FMDV genome were obtained from the National Center for Biotechnology Information (NCBI) website<sup><a href="#FN2" rid="FN2" class=" fn">1</a></sup> and compared by nucleotide (nt) BLAST. The sequence of 3D-NT19 was 5&#x02032;-GTTCTTGGTCACTCCATAA-3&#x02032;, corresponding to nt 1123&#x02013;1141 of the HKN/2002 3D gene; the sequence of 3D-NT56 was 5&#x02032;-GAGGCTATCCTCTCCTTTGCACGCCGTGGGACCATACAGGAGAAGTTGATCTCCGT-3&#x02032;, corresponding to nt 1225&#x02013;1280 of the HKN/2002 3D gene; the sequence of VP4-NT65 was 5&#x02032;-TCAGGCAACACTGGAAGCATCATTAACAACTACTACATGCAGCAGTACCAGAACTCCATGGACAC-3&#x02032;, corresponding to nt 43&#x02013;107 of the YNBS/58 VP4 gene; the sequence of VP4-NT19 was 5&#x02032;-ACAACTACTACATGCAGCA-3&#x02032;, corresponding to nt 68&#x02013;86 of the YNBS/58 VP4 gene; the sequence of 2B-NT25 was 5&#x02032;-CCAGATGCAGGAGGACATGTCAACA-3&#x02032;, corresponding to nt 57&#x02013;81 of the CHA/99 2B gene.</p></div><div id="S7" class="sec"><h3 id="S7title">2.5. Cell transfection and viral challenge assays</h3><p id="__p13" class="p p-first-last">Virus infectivity was determined by serial dilution of the sample on BHK-21 cells grown in 96-well plates and the virus titer was calculated as a tissue culture infective dose by the Reed&#x02013;Muench method [<a href="#R38" rid="R38" class=" bibr popnode">38</a>]. A viral suspension titrated at 10<sup>5</sup> to 10<sup>7</sup> TCID<sub>50</sub> per 0.1&#x000a0;mL was used for viral challenge. BHK-21 cells were seeded in 96-well plates in DMEM 24&#x000a0;h before transfection. The cells (about 95% confluent) were transiently transfected with 0.1&#x000a0;&#x003bc;g of a single plasmid expressing 3D, VP4 or 2B specific siRNA. Five hours after transfection, the transfection complex was removed, cells were washed twice with DMEM, and 100 TCID<sub>50</sub> of FMDV per 0.1&#x000a0;mL was added to each well. After 1&#x000a0;h of adsorption, the inoculum was removed and cells were washed twice with DMEM. The infection then proceeded in DMEM supplemented with 10% fetal bovine serum. Cell supernatants were collected at designated time points, and the virus titers were determined three times on BHK-21 cells. Statistical analysis was performed with the Microsoft Excel program (Microsoft, Redmond, WA, USA).</p></div><div id="S8" class="sec"><h3 id="S8title">2.6. Viral challenge assay in suckling mice</h3><p id="__p14" class="p p-first-last">Suckling mice (8 groups of 20 each) were subcutaneously injected in the neck with 100&#x000a0;&#x003bc;g of plasmids in 100&#x000a0;&#x003bc;L of phosphate-buffered saline (PBS). After 6&#x000a0;h, the suckling mice were challenged with 20 LD<sub>50</sub> of FMDV per 0.1&#x000a0;mL via subcutaneous injection into the neck near the site that received the injected DNA. The mice were then observed for 5 days post-challenge (dpc). Statistical analysis was performed with a log rank test<sup><a href="#FN3" rid="FN3" class=" fn">2</a></sup>.</p></div><div id="S9" class="sec"><h3 id="S9title">2.7. Construction and identification of recombinant attenuated <em>S</em>. <em>choleraesuis</em>\n</h3><p id="__p15" class="p p-first-last">In order to prepare the recombinants (p3D-NT19/<em>S</em>. <em>cho</em>, pLacZ/<em>S</em>. <em>cho</em> and p3D-NT56/<em>S</em>. <em>cho</em>), the attenuated <em>S</em>. <em>typhimurium</em> LB5010, an intermediate host cell, was first transformed with plasmids (pLacZ, p3D-NT56 and p3D-NT19) using a standard CaCl<sub>2</sub> method. Then, the plasmids were extracted and transferred to a terminal host cell-attenuated <em>S</em>. <em>choleraesuis</em> C500 by electroporation. The preparation of cells for electroporation was as follows: C500 cells were cultured in 3&#x000a0;mL LB medium at 200&#x000a0;rpm overnight at 37&#x000a0;&#x000b0;C, and then were inoculated into 25&#x000a0;mL liquid LB medium at 1% (v/v) at 37&#x000a0;&#x000b0;C, again with shaking at 200&#x000a0;rpm. Bacteria were grown to an optical density (OD) of 0.6&#x02013;0.7, chilled and then collected by centrifugation at 4&#x000a0;000 rpm for 10&#x000a0;min&#x000a0;at 4&#x000a0;&#x000b0;C. The cells were then washed with 10% glycerol three times. The cells were re-suspended in 10% glycerol at a concentration of 3&#x000a0;&#x000d7;&#x000a0;10<sup>10</sup> cells/mL, frozen in dry ice, and stored at &#x02212;70&#x000a0;&#x000b0;C. A 200&#x000a0;&#x003bc;L aliquot of the cells was thawed and used for transformation. One microgram DNA (the control setup with no DNA) was mixed with cold cell suspension and then transferred to a chilled cuvette. Transformation was carried out with a Bio-Rad Gene Pulser at 2.0&#x000a0;kV, 25&#x000a0;&#x003bc;F, 200&#x000a0;&#x003a9; at 0&#x02013;4&#x000a0;&#x000b0;C. Transformed competent cells were transferred to a tube, and 400&#x000a0;&#x003bc;L of media were added prior to incubating the cultures for 1.5&#x000a0;h&#x000a0;at 50&#x000a0;rpm&#x000a0;at 37&#x000a0;&#x000b0;C. Then, 80&#x000a0;&#x003bc;L of the cultures were transferred onto solid LB medium containing 100&#x000a0;&#x003bc;L/mL ampicillin. Recombinant bacteria were identified via PCR. The presence of the recombinant plasmid was confirmed by digestion with XhoI. Serological characteristics of recombinant <em>S</em>. <em>choleraesuis</em> (r<em>S</em>. <em>cho</em>) were tested using a congregation reaction on a glass plate to confirm its immunogenicity.</p></div><div id="S10" class="sec"><h3 id="S10title">2.8. Viral challenge in guinea pigs and swine</h3><p id="__p16" class="p p-first">Live bacteria were prepared by culturing cells in 25&#x000a0;mL liquid LB medium at 37&#x000a0;&#x000b0;C for 18&#x000a0;h followed by inoculation of 2.5&#x000a0;mL cultures into 25&#x000a0;mL liquid LB medium to produce 2&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup>&#x02013;5&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup>&#x000a0;CFU/mL. Live bacteria counting was performed by serial dilution of cultures followed by spread plating. Serotype O FMDV strain HKN/2002 passaged five times in suckling mice was used to challenge guinea pigs, and the virus passaged three times in swine was used for swine experiments. The viruses were titrated on guinea pigs and swine. The dose of FMDV used was determined through four 10-fold serial dilutions of virus (i.e. 10<sup>&#x02212;4</sup>, 10<sup>&#x02212;5</sup>, 10<sup>&#x02212;6</sup>, and 10<sup>&#x02212;7</sup>) in PBS. Guinea pigs (4 groups of 6 animals each) were inoculated intradermally in the left rear foot with 0.1&#x000a0;mL of serially diluted viruses. According to the method described by Chen et&#x000a0;al. [<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832951">6</a>], the swine (4 groups of 4 each) were inoculated in the neck region by intramuscular injection of each animal with 2&#x000a0;mL of serially diluted virus. All of the animals were then monitored for the major clinical sign of FMD, the appearance of vesicles on the mouth or feet. The 50% animal infective dose (ID<sub>50</sub>) was estimated using the Reed&#x02013;Muench method [<a href="#R38" rid="R38" class=" bibr popnode">38</a>]. Statistical analysis was performed with a log rank test<sup><a href="#FN3" rid="FN3" class=" fn">2</a></sup>.</p><div id="S11" class="sec"><p></p><h4 id="S11title" class="inline">2.8.1.  Guinea pig experiment 1 </h4><p id="__p17" class="p p-first-last">Guinea pigs in several groups of five each were inoculated by intramuscular injection with 1.0&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup>&#x000a0;CFU of recombinant attenuated <em>S</em>. <em>choleraesuis</em> in 0.1&#x000a0;mL of saline. Thirty-six hours after inoculation, FMDV challenge was carried out via intradermal injection of each animal with 0.1&#x000a0;mL of guinea pig infectious dose 50 ID<sub>50</sub> of HKN/2002 in the left rear foot, as was done for virus titration.</p></div><div id="S12" class="sec"><p></p><h4 id="S12title" class="inline">2.8.2.  Guinea pig experiment 2 </h4><p id="__p18" class="p p-first-last">In a parallel experiment, animals were treated with 1.0&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup> PFU of rAd5 and challenged 36&#x000a0;h later with 50 ID<sub>50</sub> of HKN/2002. To test whether the combined inoculations of rAd5 and r<em>S</em>. <em>cho</em> protected animals, some groups were injected intramuscularly with the p3D-NT56/<em>S</em>. <em>cho</em>+Ad5-POL mixture of 1.0&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup>&#x000a0;CFU and 1.0&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup> PFU, respectively; then, after 36&#x000a0;h, they were challenged with 50&#x000a0;ID<sub>50</sub> of HKN/2002.</p></div><div id="S13" class="sec sec-last"><p></p><h4 id="S13title" class="inline">2.8.3.  Swine experiment </h4><p id="__p19" class="p p-first-last">Eighteen swine were divided into 5 groups of 3 or 4 animals each. The animals in each group were co-housed in a separate room. All groups were inoculated via intramuscular injection in the neck area. Group&#x000a0;1 was a mock control group inoculated with 2&#x000a0;mL of saline. As negative controls, groups&#x000a0;2 and 3 were inoculated with 5&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup>&#x000a0;CFU of <em>S</em>. <em>choleraesuis</em> C500 or LacZ/<em>S</em>. <em>cho</em> in 2 mL of saline, respectively. Group&#x000a0;4 was inoculated with 5&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup> CFU of p3D-NT56/<em>S</em>. <em>cho</em> in 2&#x000a0;mL of saline. Group 5 was treated with a high dose of p3D-NT56/<em>S</em>. <em>cho</em> containing 5&#x000a0;&#x000d7;&#x000a0;10<sup>10</sup>&#x000a0;CFU in 2&#x000a0;mL of saline. After 24&#x000a0;h, all animals were challenged via intramuscular injection with 100&#x000a0;ID<sub>50</sub> of HKN/2002 in 2&#x000a0;mL of PBS in the neck area. To avoid overexposure to the challenge virus, animals that developed disease were moved to another room, and then observation proceeded. After challenge, the animals were examined daily for clinical signs of FMD, including an increase in body temperature (above 40&#x000a0;&#x000b0;C) and the appearance of vesicles on the mouth and feet. The lesion score was determined at various time points post-challenge by determining the number of digits plus mouth with vesicles for each animal. The observations were terminated on day 14 post-challenge, when the animals were humanely killed.</p></div></div><div id="S14" class="sec sec-last"><h3 id="S14title">2.9. Serological analysis</h3><p id="__p20" class="p p-first-last">Blood and serum samples were collected at days 7 and 14 after challenge in swine experiments. To assess the neutralizing antibody response in the swine, plaque reduction neutralization assays were performed as described previously [<a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832941">31</a>]. Neutralizing titers were reported as the highest serum dilution causing a 50% reduction in the number of HKN/2002 plaques on BHK-21 cells. The presence of antibodies against viral NS protein 3ABC of FMDV in the sera was detected using a solid-phase blocking enzyme-linked immunosorbent assay (SPB-ELISA) according to the procedures described by Chenard et&#x000a0;al. [<a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832970">7</a>]. Briefly, ELISA microtiter test plates were coated overnight at 4&#x000a0;&#x000b0;C with recombinant 3ABC antigen expressed in <em>E</em>. <em>coli</em> [<a href="#R45" rid="R45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832944">45</a>]. After five washes with PBS containing 0.05% Tween 80 (PBST), each well of the plates was filled with 100&#x000a0;&#x003bc;L of test or reference serum diluted 1:2 in PBST and incubated at 37&#x000a0;&#x000b0;C for 60&#x000a0;min. The serum was then removed, and the wells of the plates were washed as described above. After rewashing, 100&#x000a0;&#x003bc;L of anti-3ABC immunoglobulin&#x02013;horseradish peroxidase conjugate was added, and the incubation proceeded at 37&#x000a0;&#x000b0;C for 30&#x000a0;min. The conjugate was then removed, the wells of the plates were washed again, and 100&#x000a0;&#x003bc;L of a commercially ready-to-use tetramethyl benzidine chromogen substrate was added to the plates. After incubation at 37&#x000a0;&#x000b0;C for 10&#x000a0;min, the reaction was stopped by adding 50&#x000a0;&#x003bc;L of 2.0&#x000a0;M H<sub>2</sub>SO<sub>4</sub> per well, and the OD at 450&#x000a0;nm was measured by using an ELISA reader. The sera were considered positive if the OD was reduced by &#x02265;&#x000a0;30% compared to a standard negative serum corrected for background signal by subtracting the OD of the high positive reference serum. Statistical analysis was performed with the Microsoft Excel program.</p></div></div><div id="S15" class="tsec sec"><h2 class="head no_bottom_margin" id="S15title">3.\xe2\x80\x83RESULTS</h2><div id="S16" class="sec sec-first"><h3 id="S16title">3.1. FMDV-specific siRNA-expressing plasmids induced antiviral effects to different isolates of serotype O and serotype Asia I FMDV in BHK-21 cells</h3><p id="__p21" class="p p-first">To test the antiviral activity of siRNA, BHK-21 cells cultured in 96-well plates were transfected with siRNA-expressing plasmids individually. As controls, the cells were either not treated or treated with plasmid pNTH21 or pLacZ. After 24&#x000a0;h, the cells were infected with 100 TCID<sub>50</sub> of CHA/99, HNK/2002, YNBS/58 or Jiangsu/2005. The cells were observed continuously under the microscope. Microscopy examination revealed that the cells treated with p3D-NT56 or p2B-NT25 had delayed cytopathic effect (CPE) development when challenged with either serotype O or Asia I of FMDV. However, the control cells, either blank or transfected with the control plasmids, showed an extensive CPE within 24&#x000a0;h post infection (p.i.).</p><p id="__p22" class="p p-last">Furthermore, we investigated the effect of plasmid-mediated RNAi on FMDV replication by measuring the TCID<sub>50</sub> of supernatants of lysed cells, which were collected at 12, 24 and 48&#x000a0;h after viral challenge. Consistent with the observation, p3D-NT56 and p2B-NT25 showed a wider cross-inhibitory effect than the other plasmids, and these 2 plasmids inhibited 4 FMDV isolates (Fig. 1). The supernatant TCID<sub>50</sub> for CHA/99, HNK/2002, YNBS/58 and Jiangsu/2005 of the cells treated with p3D-NT56 or p2B-NT25 was reduced by 30- to 300-fold at 48&#x000a0;h post infection (Fig. 1) compared to the control groups.<!--fig ft0--><!--fig mode=article f1--></p><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC2826090/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140292921778960" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2826090_vetres-41-30-fig1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is vetres-41-30-fig1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2826090/bin/vetres-41-30-fig1.jpg" /></a></div><div id="largeobj_idm140292921778960" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2826090/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC2826090/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1.</a></div><!--caption a7--><div class="caption"><p id="__p23">Decrease of virus yield in BHK-21 cells treated with siRNA-expressing plasmids. Cells transiently transfected with either control plasmids or specific siRNA-expressing plasmids were infected with 100 TCID<sub>50</sub> of FMDV HKN/2002 (A), FMDV CHA/99 (B), FMDV YNBS/58 (C) and FMDV Jiangsu/2005 (D) per 0.1&#x000a0;mL. Culture supernatants were collected at different times, and the virus titer (TCID<sub>50</sub>) was determined three times on BHK-21 cells. Error bars indicate standard deviations.</p></div></div></div><p>\n</p></div><div id="S17" class="sec"><h3 id="S17title">3.2. Treatment with siRNA-expressing plasmids conferred resistance against FMDV in suckling mice</h3><p id="__p24" class="p p-first-last">To further examine the anti-FMDV potential of p3D-NT56 or p2B-NT25 in&#x000a0;vivo, we challenged suckling mice pretreated by subcutaneous injection of plasmids with FMDV strains HKN/2002 or YNBS/58. All PBS-treated mice died within 60&#x000a0;h after either HNK/2002 or YNBS/58 challenge (Fig. 2). The animals treated with control plasmids were also not protected at all, although death in some groups was delayed slightly (<em>p&#x000a0;=</em>&#x000a0;0.47, <em>p&#x000a0;=</em>&#x000a0;0.157) (Fig. 2). In HKN/2002 challenge experiments, 20% of the animals treated with either p3D-NT56 or p2B-NT25 were protected (Fig. 2A). The difference between the survival of mice treated with either p3D-NT56 or p2B-NT25 and the PBS control was statistically significant (<em>p</em>&#x000a0;&#x0003c;&#x000a0;0.0001). In the case of challenge with YNBS/58, 8 of 20 mice treated with p3D-NT56 and 7 of 20 mice treated with p2B-NT25 survived a viral challenge of 20 LD<sub>50</sub> (Fig. 2B), and a significant difference in mouse survival was seen between mice treated with either p3D-NT56 or p2B-NT25 and controls (<em>p</em>&#x000a0;&#x0003c;&#x000a0;0.0001). Furthermore, in both HNK/2002 and YNBS/58 challenge assays, the time of 50% death of mice was delayed for 9 to 24&#x000a0;h in groups treated with FMDV-specific siRNA-expressing plasmids as compared with control groups.<!--fig ft0--><!--fig mode=article f1--></p><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC2826090/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140292945915600" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2826090_vetres-41-30-fig2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is vetres-41-30-fig2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2826090/bin/vetres-41-30-fig2.jpg" /></a></div><div id="largeobj_idm140292945915600" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2826090/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC2826090/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2.</a></div><!--caption a7--><div class="caption"><p id="__p25">siRNA synthesized in vivo induce antiviral response in suckling mice and promote survival after FMDV infection. Suckling mice were challenged by subcutaneous injection in the neck with 20 LD<sub>50</sub> of HKN/2002 (A) or 20 LD<sub>50</sub> of YNBS/58 (B) after 6&#x000a0;h of treatment with either control plasmids or FMDV-specific siRNA-expressing plasmids. All animals were observed for 6 days after challenge.</p></div></div></div><p>\n</p></div><div id="S18" class="sec"><h3 id="S18title">3.3. FMDV-specific r<em>S</em>. <em>cho</em> constructs inhibited virus infection in guinea pigs</h3><p id="__p26" class="p p-first">The data obtained in the cell culture and suckling mice assays demonstrated that siRNA targeted to conserved regions of the FMDV genome could be effective against FMDV in either a specific or a cross-inhibitory manner. The potential of RNAi as an antiviral strategy against FMDV in relevant animal systems is of great interest. The fact that attenuated Salmonella is widely used as a DNA vaccine vector made us choose it as the vector for siRNA delivery. To test the anti-FMDV potential of r<em>S</em>. <em>cho</em>, we challenged guinea pigs pretreated by intramuscular injection of r<em>S</em>. <em>cho</em> constructs with FMDV HKN/2002. All saline-treated animals developed the major clinical sign of FMD, the appearance of vesicles on the feet, within 48&#x000a0;h of challenge (Tab. I). Guinea pigs treated with pLacZ/<em>S</em>. <em>cho</em> were not protected at all, though the clinical signs were delayed in some animals, as shown in Table I. However, 4 of 5 guinea pigs pretreated with 10<sup>9</sup>&#x000a0;CFU of p3D-NT56/<em>S</em>. <em>cho</em> and challenged with 50 ID<sub>50</sub> of HKN/2002 developed none of the clinical signs such as vesicles or high fever. These results indicated that <em>S</em>. <em>cho</em>-delivered siRNA exerted in&#x000a0;vivo inhibitory activity against FMDV in guinea pigs.<!--table ft1--><!--table-wrap mode="anchored" t5--></p><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table I.</h3><!--caption a7--><div class="caption"><p id="__p27">Treatment with FMDV-specific r<em>S</em>. <em>cho</em> or a mixture of r<em>S</em>. <em>cho</em> and rAd5 inhibits FMDV HKN/2002 infection in guinea pigs<sup><a href="#TFN1" rid="TFN1" class=" fn">a</a></sup>.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140292933154848" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr valign="top"><th align="left" rowspan="2" colspan="1">Group</th><th align="center" rowspan="2" colspan="1">Treatment (CFU or PFU)<sup><a href="#TFN2" rid="TFN2" class=" fn">b</a></sup></th><th align="center" colspan="7" rowspan="1">No. protected/no. challenged for dpc<hr /></th><th align="center" rowspan="2" colspan="1"><em>p</em><sup><a href="#TFN3" rid="TFN3" class=" fn">c</a></sup></th></tr><tr valign="top"><th align="center" rowspan="1" colspan="1">1</th><th align="center" rowspan="1" colspan="1">2</th><th align="center" rowspan="1" colspan="1">3</th><th align="center" rowspan="1" colspan="1">4</th><th align="center" rowspan="1" colspan="1">5</th><th align="center" rowspan="1" colspan="1">6</th><th align="center" rowspan="1" colspan="1">14</th></tr></thead><tbody><tr valign="top"><td align="left" rowspan="1" colspan="1">Saline</td><td align="left" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">3/5</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">AC</td></tr><tr valign="top"><td align="left" rowspan="1" colspan="1">pLacZ/<em>S</em>. <em>cho</em></td><td align="center" rowspan="1" colspan="1">10<sup>9</sup></td><td align="center" rowspan="1" colspan="1">4/5</td><td align="center" rowspan="1" colspan="1">1/5</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">0.308</td></tr><tr valign="top"><td align="left" rowspan="1" colspan="1">p3D-NT56/<em>S</em>. <em>cho</em></td><td align="center" rowspan="1" colspan="1">10<sup>9</sup></td><td align="center" rowspan="1" colspan="1">5/5</td><td align="center" rowspan="1" colspan="1">5/5</td><td align="center" rowspan="1" colspan="1">4/5</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">0.00313</td></tr><tr valign="top"><td align="left" rowspan="1" colspan="1">p3D-NT19/<em>S</em>. <em>cho</em></td><td align="center" rowspan="1" colspan="1">10<sup>9</sup></td><td align="center" rowspan="1" colspan="1">5/5</td><td align="center" rowspan="1" colspan="1">2/5</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">0.0571</td></tr><tr valign="top"><td align="left" rowspan="1" colspan="1"><em>S</em>. <em>cho</em></td><td align="center" rowspan="1" colspan="1">10<sup>9</sup></td><td align="center" rowspan="1" colspan="1">1/5</td><td align="center" rowspan="1" colspan="1">1/5</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">0.787</td></tr><tr valign="top"><td align="left" rowspan="1" colspan="1">pLacZ/<em>S</em>. <em>cho</em></td><td align="center" rowspan="1" colspan="1">10<sup>8</sup></td><td align="center" rowspan="1" colspan="1">4/5</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">0.513</td></tr><tr valign="top"><td align="left" rowspan="1" colspan="1">p3D-NT56/<em>S</em>. <em>cho</em></td><td align="center" rowspan="1" colspan="1">10<sup>8</sup></td><td align="center" rowspan="1" colspan="1">5/5</td><td align="center" rowspan="1" colspan="1">3/5</td><td align="center" rowspan="1" colspan="1">2/5</td><td align="center" rowspan="1" colspan="1">2/5</td><td align="center" rowspan="1" colspan="1">1/5</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">0.029</td></tr><tr valign="top"><td align="left" rowspan="1" colspan="1">pLacZ/<em>S</em>. <em>cho</em></td><td align="center" rowspan="1" colspan="1">10<sup>10</sup></td><td align="center" rowspan="1" colspan="1">5/5</td><td align="center" rowspan="1" colspan="1">1/5</td><td align="center" rowspan="1" colspan="1">1/5</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">0.0951</td></tr><tr valign="top"><td align="left" rowspan="1" colspan="1">p3D-NT56/<em>S</em>. <em>cho</em></td><td align="center" rowspan="1" colspan="1">10<sup>10</sup></td><td align="center" rowspan="1" colspan="1">5/5</td><td align="center" rowspan="1" colspan="1">4/5</td><td align="center" rowspan="1" colspan="1">2/5</td><td align="center" rowspan="1" colspan="1">2/5</td><td align="center" rowspan="1" colspan="1">1/5</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">0.0116</td></tr><tr valign="top"><td align="left" rowspan="1" colspan="1">Ad5-LacZ+pLacZ/<em>S</em>. <em>cho</em></td><td align="center" rowspan="1" colspan="1">10<sup>6</sup>&#x000a0;+&#x000a0;10<sup>9</sup></td><td align="center" rowspan="1" colspan="1">2/5</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">0.549</td></tr><tr valign="top"><td align="left" rowspan="1" colspan="1">Ad5-POL+p3D-NT56/<em>S</em>. <em>cho</em></td><td align="center" rowspan="1" colspan="1">10<sup>6</sup>&#x000a0;+&#x000a0;10<sup>9</sup></td><td align="center" rowspan="1" colspan="1">5/5</td><td align="center" rowspan="1" colspan="1">3/5</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">0.029</td></tr><tr valign="top"><td align="left" rowspan="1" colspan="1">Ad5-LacZ</td><td align="center" rowspan="1" colspan="1">10<sup>6</sup></td><td align="center" rowspan="1" colspan="1">3/5</td><td align="center" rowspan="1" colspan="1">1/5</td><td align="center" rowspan="1" colspan="1">1/5</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">0.602</td></tr><tr valign="top"><td align="left" rowspan="1" colspan="1">Ad5-POL</td><td align="center" rowspan="1" colspan="1">10<sup>6</sup></td><td align="center" rowspan="1" colspan="1">5/5</td><td align="center" rowspan="1" colspan="1">5/5</td><td align="center" rowspan="1" colspan="1">3/5</td><td align="center" rowspan="1" colspan="1">2/5</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">0.00313</td></tr></tbody></table></div><div id="largeobj_idm140292933154848" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2826090/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><sup>a</sup>&#x02013;: Score is the same as the day before.</div><div id="TFN2"><sup>b</sup>CFU for r<em>S</em>. <em>cho</em> and PFU for rAd5.</div><div id="TFN3"><sup>c</sup>Statistical analysis by the log rank test.</div><p id="__p31">Days post-challenge (dpc) and AC: as controls.</p></div></div><p>\n</p><p id="__p32" class="p p-last">We further evaluated the potential of treatments with an FMDV-specific r<em>S</em>. <em>cho</em> and rAd5 mixture in guinea pigs. Three of the five animals in the group treated with the p3D-NT56/<em>S</em>. <em>cho</em>+Ad5-POL mixture were completely protected as determined by the absence of vesicles on their feet (Tab. I). No significant increase in antiviral effect was achieved in this group when compared to the group treated with p3D-NT56/<em>S</em>. <em>cho</em> alone (Tab. I). This indicated that a simple combination of two vectors could not improve the protection of animals.</p></div><div id="S19" class="sec sec-last"><h3 id="S19title">3.4. Treatment with p3D-NT56/<em>S</em>. <em>cho</em> confers significant resistance against FMDV infection in swine</h3><p id="__p33" class="p p-first">Based on the experiments in guinea pigs, we evaluated the antiviral activity of p3D-NT56/<em>S</em>. <em>cho</em> in swine. Animals were intramuscularly inoculated with 5&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup>&#x000a0;CFU of p3D-NT56/<em>S</em>. <em>cho</em> and challenged 24&#x000a0;h later with 100 ID<sub>50</sub> of HKN/2002. All of the saline-treated swine developed acute signs of FMD, including vesicles and fever (Fig. 3A). Animal 1-48 had vesicles as early as 3&#x000a0;dpc, and its symptoms were extraordinarily severe. In comparison with this group, animals inoculated with either pLacZ/<em>S</em>. <em>cho</em> or <em>S</em>. <em>cho</em> showed no signs of significant antiviral activity (Figs. 3B and 3C). However, p3D-NT56/<em>S</em>. <em>cho</em> conferred marked antiviral activity that could be seen for more than 9 days of observation (Fig. 3D). Animal 2-7 in this group developed a fever but no vesicles during the observation period. Although animals 5-6, 3-3 and 1-1 developed vesicles, they were fewer and developed much later. In another group inoculated with 5&#x000a0;&#x000d7;&#x000a0;10<sup>10</sup>&#x000a0;CFU of p3D-NT56/<em>S</em>. <em>cho</em>, none of the animals were protected (Fig. 3E), but animal 7-1 showed delayed disease onset and milder disease than the control animals.<!--fig ft0--><!--fig mode=article f1--></p><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC2826090/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140292933669840" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2826090_vetres-41-30-fig3.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is vetres-41-30-fig3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2826090/bin/vetres-41-30-fig3.jpg" /></a></div><div id="largeobj_idm140292933669840" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2826090/figure/F3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC2826090/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3.</a></div><!--caption a7--><div class="caption"><p id="__p34">Antiviral activity of r<em>S</em>. <em>cho</em> in swine. Animals were treated with saline (A), <em>S</em>. <em>cho</em> (B), pLacZ/<em>S</em>. <em>cho</em> (C), p3D-NT56/<em>S</em>. <em>cho</em> (D), or a high dose of p3D-NT56/<em>S</em>. <em>cho</em> (E) and challenged as described in the Materials and Methods section. After challenge, lesion scores were assigned to the animals according to the number of digits plus mouth with vesicles.</p></div></div></div><p>\n</p><p id="__p35" class="p p-last">Serum samples were collected at 0, 7, and 14&#x000a0;dpc and tested for the presence of neutralizing antibodies and antibodies against viral NS protein 3ABC of FMDV. No animals had marked FMDV-specific antibodies at 0&#x000a0;dpc, including anti-3ABC antibodies (Tab. II). Animals in the control groups treated with saline, <em>S</em>. <em>cho</em> or pLacZ/<em>S</em>. <em>cho</em> developed a high neutralizing antibody response at 7 and 14&#x000a0;dpc, suggesting that these animals were exposed to a very large amount of FMDV (Tab. II). A very low neutralizing antibody response was detected at 7&#x000a0;dpc in animals (2-7, 5-6, 3-3, 1-1, 7-1 and 1-34) that were inoculated with p3D-NT56/<em>S</em>. <em>cho</em>, suggesting that these animals effectively suppressed virus replication. A key distinguishing feature of infected animals is the induction of antibodies against the polyprotein 3ABC of FMDV [<a href="#R45" rid="R45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832956">45</a>]. Using an LPB-ELISA, we showed that the animals developing FMD had significantly higher levels of antibodies against 3ABC as compared to the disease-free animals (Tab. II). These results of serological analysis were consistent with the observation of clinical signs.<!--table ft1--><!--table-wrap mode="anchored" t5--></p><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table II.</h3><!--caption a7--><div class="caption"><p id="__p36">Serological analysis of sera from swine inoculated with r<em>S</em>. <em>cho</em>.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140292935888128" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr valign="top"><th align="left" rowspan="2" colspan="1">Group</th><th align="center" rowspan="2" colspan="1">Animal no.</th><th align="center" colspan="3" rowspan="1">Neutralizing antibody<sup><a href="#TFN4" rid="TFN4" class=" fn">a</a></sup><hr /></th><th align="center" colspan="3" rowspan="1">Mean % inhibition of antibody against 3ABC<sup><a href="#TFN5" rid="TFN5" class=" fn">b</a></sup>&#x000a0;&#x000b1;&#x000a0;SD<hr /></th></tr><tr valign="top"><th align="center" rowspan="1" colspan="1">Day 0</th><th align="center" rowspan="1" colspan="1">Day 7</th><th align="center" rowspan="1" colspan="1">Day 14</th><th align="center" rowspan="1" colspan="1">Day 0</th><th align="center" rowspan="1" colspan="1">Day 7</th><th align="center" rowspan="1" colspan="1">Day 14</th></tr></thead><tbody><tr valign="top"><td align="left" rowspan="3" colspan="1">Saline</td><td align="center" rowspan="1" colspan="1">28-8</td><td align="center" rowspan="1" colspan="1">&#x02264;&#x000a0;3</td><td align="center" rowspan="1" colspan="1">108</td><td align="center" rowspan="1" colspan="1">362</td><td align="center" rowspan="1" colspan="1">ND<sup><a href="#TFN7" rid="TFN7" class=" fn">c</a></sup></td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td></tr><tr valign="top"><td align="center" rowspan="1" colspan="1">1-48</td><td align="center" rowspan="1" colspan="1">&#x02264;&#x000a0;3</td><td align="center" rowspan="1" colspan="1">362</td><td align="center" rowspan="1" colspan="1">362</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td></tr><tr valign="top"><td align="center" rowspan="1" colspan="1">3-2</td><td align="center" rowspan="1" colspan="1">&#x02264;&#x000a0;3</td><td align="center" rowspan="1" colspan="1">128</td><td align="center" rowspan="1" colspan="1">362</td><td align="center" rowspan="1" colspan="1">2.6&#x000a0;&#x000b1;&#x000a0;0.2</td><td align="center" rowspan="1" colspan="1">39.5&#x000a0;&#x000b1;&#x000a0;0.1</td><td align="center" rowspan="1" colspan="1">36.2&#x000a0;&#x000b1;&#x000a0;2.0</td></tr><tr valign="top"><td align="left" rowspan="2" colspan="1"><em>S</em>. <em>cho</em></td><td align="center" rowspan="1" colspan="1">6-4</td><td align="center" rowspan="1" colspan="1">&#x02264;&#x000a0;3</td><td align="center" rowspan="1" colspan="1">362</td><td align="center" rowspan="1" colspan="1">362</td><td align="center" rowspan="1" colspan="1">12.9&#x000a0;&#x000b1;&#x000a0;2.9</td><td align="center" rowspan="1" colspan="1">42.9&#x000a0;&#x000b1;&#x000a0;1.1</td><td align="center" rowspan="1" colspan="1">55.9&#x000a0;&#x000b1;&#x000a0;1.1</td></tr><tr valign="top"><td align="center" rowspan="1" colspan="1">4-6</td><td align="center" rowspan="1" colspan="1">&#x02264;&#x000a0;3</td><td align="center" rowspan="1" colspan="1">180</td><td align="center" rowspan="1" colspan="1">362</td><td align="center" rowspan="1" colspan="1">13.6&#x000a0;&#x000b1;&#x000a0;1.9</td><td align="center" rowspan="1" colspan="1">54.5&#x000a0;&#x000b1;&#x000a0;1.9</td><td align="center" rowspan="1" colspan="1">63.2&#x000a0;&#x000b1;&#x000a0;0.7</td></tr><tr valign="top"><td align="left" rowspan="4" colspan="1">pLacZ/<em>S</em>. <em>cho</em></td><td align="center" rowspan="1" colspan="1">6-2</td><td align="center" rowspan="1" colspan="1">&#x02264;&#x000a0;3</td><td align="center" rowspan="1" colspan="1">180</td><td align="center" rowspan="1" colspan="1">362</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td></tr><tr valign="top"><td align="center" rowspan="1" colspan="1">43-14</td><td align="center" rowspan="1" colspan="1">&#x02264;&#x000a0;3</td><td align="center" rowspan="1" colspan="1">180</td><td align="center" rowspan="1" colspan="1">362</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td></tr><tr valign="top"><td align="center" rowspan="1" colspan="1">43-5</td><td align="center" rowspan="1" colspan="1">&#x02264;&#x000a0;3</td><td align="center" rowspan="1" colspan="1">256</td><td align="center" rowspan="1" colspan="1">256</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td></tr><tr valign="top"><td align="center" rowspan="1" colspan="1">49-3</td><td align="center" rowspan="1" colspan="1">&#x02264;&#x000a0;3</td><td align="center" rowspan="1" colspan="1">128</td><td align="center" rowspan="1" colspan="1">180</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td></tr><tr valign="top"><td align="left" rowspan="4" colspan="1">p3D-NT56/<em>S</em>. <em>cho</em></td><td align="center" rowspan="1" colspan="1">2-7</td><td align="center" rowspan="1" colspan="1">&#x02264;&#x000a0;3</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">180</td><td align="center" rowspan="1" colspan="1">12.16&#x000a0;&#x000b1;&#x000a0;1.1</td><td align="center" rowspan="1" colspan="1">12.6&#x000a0;&#x000b1;&#x000a0;2.4</td><td align="center" rowspan="1" colspan="1">25.8&#x000a0;&#x000b1;&#x000a0;0.4</td></tr><tr valign="top"><td align="center" rowspan="1" colspan="1">5-6</td><td align="center" rowspan="1" colspan="1">&#x02264;&#x000a0;3</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">180</td><td align="center" rowspan="1" colspan="1">6.5&#x000a0;&#x000b1;&#x000a0;1.0</td><td align="center" rowspan="1" colspan="1">10.1&#x000a0;&#x000b1;&#x000a0;0.3</td><td align="center" rowspan="1" colspan="1">27.8&#x000a0;&#x000b1;&#x000a0;4.2</td></tr><tr valign="top"><td align="center" rowspan="1" colspan="1">3-3</td><td align="center" rowspan="1" colspan="1">&#x02264;&#x000a0;3</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">180</td><td align="center" rowspan="1" colspan="1">12.8&#x000a0;&#x000b1;&#x000a0;0.8</td><td align="center" rowspan="1" colspan="1">9.5&#x000a0;&#x000b1;&#x000a0;0.2</td><td align="center" rowspan="1" colspan="1">32.9&#x000a0;&#x000b1;&#x000a0;5.2</td></tr><tr valign="top"><td align="center" rowspan="1" colspan="1">1-1</td><td align="center" rowspan="1" colspan="1">&#x02264;&#x000a0;3</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">180</td><td align="center" rowspan="1" colspan="1">11.9&#x000a0;&#x000b1;&#x000a0;0.5</td><td align="center" rowspan="1" colspan="1">21.2&#x000a0;&#x000b1;&#x000a0;3.8</td><td align="center" rowspan="1" colspan="1">29.5&#x000a0;&#x000b1;&#x000a0;2.7</td></tr><tr valign="top"><td align="left" rowspan="4" colspan="1">p3D-NT56/<em>S</em>. <em>cho</em><sup><a href="#TFN7" rid="TFN7" class=" fn">d</a></sup></td><td align="center" rowspan="1" colspan="1">1-3</td><td align="center" rowspan="1" colspan="1">&#x02264;&#x000a0;3</td><td align="center" rowspan="1" colspan="1">108</td><td align="center" rowspan="1" colspan="1">128</td><td align="center" rowspan="1" colspan="1">3.1&#x000a0;&#x000b1;&#x000a0;1.0</td><td align="center" rowspan="1" colspan="1">36.5&#x000a0;&#x000b1;&#x000a0;1.2</td><td align="center" rowspan="1" colspan="1">50.0&#x000a0;&#x000b1;&#x000a0;4.3</td></tr><tr valign="top"><td align="center" rowspan="1" colspan="1">7-1</td><td align="center" rowspan="1" colspan="1">&#x02264;&#x000a0;3</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">180</td><td align="center" rowspan="1" colspan="1">6.4&#x000a0;&#x000b1;&#x000a0;0.0</td><td align="center" rowspan="1" colspan="1">27.9&#x000a0;&#x000b1;&#x000a0;0.2</td><td align="center" rowspan="1" colspan="1">33.6&#x000a0;&#x000b1;&#x000a0;3.2</td></tr><tr valign="top"><td align="center" rowspan="1" colspan="1">3-4</td><td align="center" rowspan="1" colspan="1">&#x02264;&#x000a0;3</td><td align="center" rowspan="1" colspan="1">108</td><td align="center" rowspan="1" colspan="1">180</td><td align="center" rowspan="1" colspan="1">7.4&#x000a0;&#x000b1;&#x000a0;0.7</td><td align="center" rowspan="1" colspan="1">39.1&#x000a0;&#x000b1;&#x000a0;1.8</td><td align="center" rowspan="1" colspan="1">45.5&#x000a0;&#x000b1;&#x000a0;0.2</td></tr><tr valign="top"><td align="center" rowspan="1" colspan="1">1-34</td><td align="center" rowspan="1" colspan="1">&#x02264;&#x000a0;3</td><td align="center" rowspan="1" colspan="1">64</td><td align="center" rowspan="1" colspan="1">180</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td></tr></tbody></table></div><div id="largeobj_idm140292935888128" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2826090/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN4"><sup>a</sup>Highest dilution that resulted in a 50% reduction in the number of HKN/2002 plaques.</div><div id="TFN5"><sup>b</sup>Mean percent inhibition of the optical density as determined by ELISA.</div><div id="TFN6"><sup>c</sup>ND: not determined.</div><div id="TFN7"><sup>d</sup>Inoculation with a high dose of r<em>S</em>. <em>cho</em>.</div></div></div><p>\n</p></div></div><div id="S20" class="tsec sec"><h2 class="head no_bottom_margin" id="S20title">4.\xe2\x80\x83DISCUSSION</h2><p id="__p41" class="p p-first">Strategies aimed at conferring rapid and efficient protection against FMDV have to face one main challenging factor: the rapid, acute infection caused by this virus, which makes the absence of sufficient amounts of antibodies or other interfering factors essential for protection. The traditional emergency vaccines based on virus inactivation could be effective in preventing disease within 4 to 5 days post-vaccination, due to a critical role for innate immune defenses [<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832940">2</a>, <a href="#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832939">39</a>]. However, signs of disease can appear as early as 2 days post-exposure. Thus, it is necessary to develop antiviral strategies capable of inducing early protection in the face of an outbreak that threatens to spread widely. Recently, we and several other groups demonstrated that RNAi can be potentially used as a therapeutic or prophylactic mechanism against FMDV [<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832969">6</a>, <a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832966">24</a>, <a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832968">33</a>]. However, to be effective against RNA viruses such as FMDV, which are highly antigenically variable, the siRNA must be targeted to conserved regions. Here, we provide evidence that siRNA targeted to conserved regions of the FMDV genome could effectively inhibit the virus replication of multiple FMDV serotypes.</p><p id="__p42">In this study, three genes, namely 3D, VP4 and 2B, were selected as targets for three reasons. First, it is well known that different siRNA have different efficiencies in inducing RNAi [<a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832943">21</a>&#x02013;<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832975">23</a>]. Second, the proteins encoded by these genes have essential functions in different phases of the viral replication cycle. The RNA-dependent RNA polymerase (3D) is a key enzyme in viral RNA replication [<a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832986">34</a>, <a href="#R44" rid="R44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832936">44</a>]; VP4 is a structural protein, located inside the mature virus particle, and is involved in conversion of provirions to mature virions [<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832960">1</a>]; and 2B is involved in membrane rearrangements required for viral RNA replication and capsid assembly [<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832963">19</a>]. Third, we compared 14 reported FMDV isolates of serotype O and serotype Asia I. The analysis showed that the sequences in these regions are relatively conserved between different FMDV serotypes. Previously, De los Santos et&#x000a0;al. [<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832957">11</a>] found that an siRNA directed against a conserved sequence within the coding region of viral NS protein 2B of FMDV was capable of inhibiting virus replication in infected porcine cells by approximately 97&#x02013;98%. And this 2B-specific siRNA reduced virus yield in cells infected with 4 different FMDV serotypes. Liu et al. [<a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832982">28</a>] demonstrated that siRNA directed to the conserved regions of the FMDV genome, namely VP4 and 3D, could inhibit the replication of both FMDV strains, serotype O and Asia I. Our study indicates that p3D-NT56 and p2B-NT25 dramatically inhibited viral replication in cultured cells that were susceptible to FMDV of either serotype O or serotype Asia I. Suckling mice treated with the siRNA-expressing plasmids had significantly reduced susceptibility to both serotype O and serotype Asia I of FMDV.</p><p id="__p43">Efficient delivery of siRNA into cells or organs in vivo remains a major bottleneck in antiviral therapy. A number of methods for delivering siRNA in vivo have been tested [<a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832950">3</a>, <a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832955">15</a>, <a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832933">27</a>, <a href="#R49" rid="R49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832977">49</a>]. Liposome formulations are generally used [<a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832949">3</a>, <a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832976">15</a>, <a href="#R49" rid="R49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832942">49</a>], but a simple intranasal administration of naked siRNA has been shown to be effective against respiratory viruses [<a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832987">3</a>]. Chen et&#x000a0;al. [<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832978">6</a>] used adenoviruses as the vectors for the delivery of duplex RNA to the target tissue, and total RNA were extracted from five tissues (oropharynx, lung, liver, muscle, and epidermis of the foot) of guinea pigs treated with rAd5 and assayed for rAd5 GFP mRNA. The vast majority of rAd5 was found in the liver. In cloven-hoofed animals, the oropharynx has been identified as the major site of FMDV replication during acute and persistent infection [<a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832948">37</a>]. Brown et&#x000a0;al. [<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832980">4</a>] indicated that the FMDV RNA was localized in the tonsil, pharynx and the tracheo-bronchial lymph node. The different tissue distribution of rAd5 and FMDV is probably related to antiviral activity of rAd5 in vivo. Our overall goal was to find a siRNA vector that can spread through the similar infection and transmission tract as FMDV. Attenuated Salmonella has become popular for expressing foreign antigens as a vaccine strain or as a delivery vector of DNA vaccines [<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832973">10</a>, <a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_313153634">12</a>]. Gray et&#x000a0;al. [<a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832959">18</a>] found that <em>S</em>. <em>choleraesuis</em> was most often recovered from the lymph node, tonsil, lung and alimentary tract of swine inoculated with <em>S</em>. <em>choleraesuis</em>. These studies aroused our interest in evaluating the potential of Salmonella as a vector for siRNA delivery. We found that 80% of guinea pigs were completely protected when inoculated with 10<sup>9</sup> CFU of p3D-NT56/r<em>S</em>. <em>cho</em>, and that r<em>S</em>. <em>cho</em> also conferred marked antiviral activity in swine. Surprisingly, the antiviral potential of RNAi was evidently impaired in animals treated with a high dose of r<em>S</em>. <em>cho</em>. Srinivasan et al. [<a href="#R43" rid="R43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832961">43</a>] demonstrated that variation in the initial dose of infection with <em>Salmonella</em> had a profound effect on the response of <em>Salmonella</em> flagellin-specific CD4 T cells in vivo, and that low-dose infection could evade <em>Salmonella</em> flagellin-specific T cell activation completely. Mercado et&#x000a0;al. [<a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832954">32</a>] reported that a 25-fold dilution in bacterial challenge dose did not significantly alter the size or kinetics of the <em>Listeria</em> LLO<sub>91&#x02013;99</sub>-specific CD8 T cell response. The low-dose effect may represent a general mechanism to increase virulence. The immune evasion could probably make the lower dose salmonella more efficient as a vector to carry siRNA.</p><p id="__p44">Because Ad5 lacking E1A and E1B had been used for delivery of RNAi by several groups [<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832937">6</a>, <a href="#R40" rid="R40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832971">40</a>, <a href="#R48" rid="R48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832953">48</a>], we evaluated the antiviral potential of combination inoculations of r<em>S</em>. <em>cho</em> and rAd5 in guinea pigs. The results indicate that no significant increase in antiviral effect was achieved in the group treated with the p3D-NT56/<em>S</em>. <em>cho</em>+Ad5-POL mixture, as compared to the group treated with p3D-NT56/<em>S</em>. <em>cho</em> alone. Kim et&#x000a0;al. [<a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224832947">25</a>] attempted to improve the antiviral effect by use of a mixture of two adenovirus constructs, by giving two injections of shRNA prior to FMDV challenge and by giving injections after FMDV challenge. The high survival rate was maintained by treatment with adenoviruses post-challenge. These results could encourage us to seek more efficient methods of treatment.</p><p id="__p45" class="p p-last">In conclusion, a licensed strain of <em>S</em>. <em>choleraesuis</em> has a potential as an RNAi delivery system. This strain is very safe for swine, relatively inexpensive to manufacture and well suited for large-scale administration. However, it remains unclear the attenuated Salmonella how to deliver siRNA in&#x000a0;vivo. Future studies relevant to cytokine and distribution of siRNA are necessary to examine this issue in more detail.</p></div><div id="idm140292936414864" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140292936414864title">Acknowledgments</h2><div class="sec"><p id="__p46">We thank Peng Hao, Xuecen Xie, Lijun Wang, Yanhong Zhang, Yanqi Sun and Tailiang Sun for technical assistance. This work was supported by High-Tech Projects both of 2008ZX08006-001 and 2008ZX08007-004 to Z. Zheng and W. Yan.</p></div></div><div id="idm140292936414000" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140292936414000title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN2"><sup>1</sup>\n<a href="http://www.ncbi.nlm.nih.gov" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.ncbi.nlm.nih.gov</a>\n</p><p class="fn sec" id="FN3"><sup>2</sup>\n<a href="http://bioinf.wehi.edu.au/software/russell/logrank/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://bioinf.wehi.edu.au/software/russell/logrank/</a>\n</p></div></div><div id="idm140292934579984" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140292934579984title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="mixed-citation">Bachrach H.L., <span class="ref-title">Foot-and-mouth disease virus</span>, <span class="ref-journal">Annu. Rev. Microbiol.</span> (1968) <span class="ref-vol">22</span>:201&#x02013;244 [<a href="/pubmed/4301615" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu.+Rev.+Microbiol.&amp;title=Foot-and-mouth+disease+virus&amp;volume=22&amp;publication_year=1968&amp;pages=201-244&amp;pmid=4301615&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="mixed-citation">Barnett P.V., Carabin H., <span class="ref-title">A review of emergency foot-and-mouth disease (FMD) vaccines</span>, <span class="ref-journal">Vaccine</span> (2002) <span class="ref-vol">20</span>:1505&#x02013;1514 [<a href="/pubmed/11858856" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=A+review+of+emergency+foot-and-mouth+disease+(FMD)+vaccines&amp;volume=20&amp;publication_year=2002&amp;pages=1505-1514&amp;pmid=11858856&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="mixed-citation">Bitko V., Musiyenko A., Shulyayeva O., Barik S., <span class="ref-title">Inhibition of respiratory viruses by nasally administered siRNA</span>, <span class="ref-journal">Nat. Med.</span> (2005) <span class="ref-vol">11</span>:50&#x02013;55 [<a href="/pubmed/15619632" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Med.&amp;title=Inhibition+of+respiratory+viruses+by+nasally+administered+siRNA&amp;volume=11&amp;publication_year=2005&amp;pages=50-55&amp;pmid=15619632&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="mixed-citation">Brown C.C., Piccone M.E., Mason P.W., McKenna T.S.-C., Grubman M.J., <span class="ref-title">Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle</span>, <span class="ref-journal">J. Virol.</span> (1996) <span class="ref-vol">70</span>:5638&#x02013;5641 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC190525/">PMC free article</a>]</span> [<a href="/pubmed/8764079" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Virol.&amp;title=Pathogenesis+of+wild-type+and+leaderless+foot-and-mouth+disease+virus+in+cattle&amp;volume=70&amp;publication_year=1996&amp;pages=5638-5641&amp;pmid=8764079&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="mixed-citation">Chen W., Yan W., Du Q., Fei L., Liu M., Ni Z., et al., <span class="ref-title">RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice</span>, <span class="ref-journal">J. Virol.</span> (2004) <span class="ref-vol">78</span>:6900&#x02013;6907 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC421660/">PMC free article</a>]</span> [<a href="/pubmed/15194766" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Virol.&amp;title=RNA+interference+targeting+VP1+inhibits+foot-and-mouth+disease+virus+replication+in+BHK-21+cells+and+suckling+mice&amp;volume=78&amp;publication_year=2004&amp;pages=6900-6907&amp;pmid=15194766&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="mixed-citation">Chen W., Liu M., Jiao Y., Yan W., Wei X., Chen J., et al., <span class="ref-title">Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo</span>, <span class="ref-journal">J. Virol.</span> (2006) <span class="ref-vol">80</span>:3559&#x02013;3566 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1440392/">PMC free article</a>]</span> [<a href="/pubmed/16537624" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Virol.&amp;title=Adenovirus-mediated+RNA+interference+against+foot-and-mouth+disease+virus+infection+both+in+vitro+and+in+vivo&amp;volume=80&amp;publication_year=2006&amp;pages=3559-3566&amp;pmid=16537624&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="mixed-citation">Chenard G., Miedema K., Moonen P., Schrijver R.S., Dekker A., <span class="ref-title">A solid-phase blocking ELISA for detection of type O foot-and-mouth disease virus antibodies suitable for mass serology</span>, <span class="ref-journal">J. Virol. Methods</span> (2003) <span class="ref-vol">107</span>:89&#x02013;98 [<a href="/pubmed/12445942" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Virol.+Methods&amp;title=A+solid-phase+blocking+ELISA+for+detection+of+type+O+foot-and-mouth+disease+virus+antibodies+suitable+for+mass+serology&amp;volume=107&amp;publication_year=2003&amp;pages=89-98&amp;pmid=12445942&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="mixed-citation">Curtiss R.T., Hassan J.O., Herr J., Kelly S.M., Levine M., Mahairas G.G., et al., <span class="ref-title">Nonrecombinant and recombinant avirulent salmonella vaccine</span>, in: Talwar G.P., Rao K.V.S., Chauhan V.S. (Eds.), <span class="ref-journal">Recombinant and synthetic vaccines</span>, Norosa Publishing House, New Delhi, India, 1994, pp. 340&#x02013;351 <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Recombinant+and+synthetic+vaccines&amp;publication_year=1994&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="mixed-citation">Darji A., Guzman C.A., Gerstel B., Wachholz P., Timmis K.N., Wehland J., et al., <span class="ref-title">Oral somatic transgene vaccination using attenuated <em>S</em>. <em>typhimurium</em></span>, <span class="ref-journal">Cell</span> (1997) <span class="ref-vol">91</span>:765&#x02013;775 [<a href="/pubmed/9413986" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Oral+somatic+transgene+vaccination+using+attenuated+S.+typhimurium&amp;volume=91&amp;publication_year=1997&amp;pages=765-775&amp;pmid=9413986&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="mixed-citation">Darji A., Lage S.Z., Garbe A.I., Chakraborty T., Weiss S., <span class="ref-title">Oral delivery of DNA vaccines using attenuated <em>Salmonella typhimurium</em> as carrier</span>, <span class="ref-journal">FEMS Immunol. Med. Microbiol.</span> (2000) <span class="ref-vol">27</span>:341&#x02013;349 [<a href="/pubmed/10727890" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FEMS+Immunol.+Med.+Microbiol.&amp;title=Oral+delivery+of+DNA+vaccines+using+attenuated+Salmonella+typhimurium+as+carrier&amp;volume=27&amp;publication_year=2000&amp;pages=341-349&amp;pmid=10727890&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="mixed-citation">De los Santos T., Wu Q., de Avila Botton S., Grubman M.J., <span class="ref-title">Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus</span>, <span class="ref-journal">Virology</span> (2005) <span class="ref-vol">335</span>:222&#x02013;231 [<a href="/pubmed/15840521" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Short+hairpin+RNA+targeted+to+the+highly+conserved+2B+nonstructural+protein+coding+region+inhibits+replication+of+multiple+serotypes+of+foot-and-mouth+disease+virus&amp;volume=335&amp;publication_year=2005&amp;pages=222-231&amp;pmid=15840521&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="mixed-citation">Dietrich G., Gentschev I., Hess J., Ulmer J.B., Kaufmann S.H.E., Goebel W., <span class="ref-title">Delivery of DNA vaccines by attenuated intracellular bacteria</span>, <span class="ref-journal">Trends Immunol. Today</span> (1999) <span class="ref-vol">20</span>:251&#x02013;253 [<a href="/pubmed/10354548" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Immunol.+Today&amp;title=Delivery+of+DNA+vaccines+by+attenuated+intracellular+bacteria&amp;volume=20&amp;publication_year=1999&amp;pages=251-253&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="mixed-citation">Fang X.W., Li Y.L., Huang C.B., Zheng M., Feng W.D., Sun W., <span class="ref-title">Live vaccine against swine paratyphoid from the attenuated smooth strain C500 of <em>Salmonella choleraesuis</em></span>, <span class="ref-journal">Acta Veterinaria Zootechnica Sinica</span> (1981) <span class="ref-vol">12</span>:99&#x02013;106 <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Veterinaria+Zootechnica+Sinica&amp;title=Live+vaccine+against+swine+paratyphoid+from+the+attenuated+smooth+strain+C500+of+Salmonella+choleraesuis&amp;volume=12&amp;publication_year=1981&amp;pages=99-106&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="mixed-citation">Fountaine T.M., Wood M.J.A., Wade-Martins R., <span class="ref-title">Delivering RNA interference to the mammalian brain</span>, <span class="ref-journal">Curr. Gene Ther.</span> (2005) <span class="ref-vol">5</span>:399&#x02013;410 [<a href="/pubmed/16101514" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr.+Gene+Ther.&amp;title=Delivering+RNA+interference+to+the+mammalian+brain&amp;volume=5&amp;publication_year=2005&amp;pages=399-410&amp;pmid=16101514&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="mixed-citation">Geisbert T.W., Hensley L.E., Kagan E., Yu E.Z., Geisbert J.B., Daddario-DiCaprio K., et al., <span class="ref-title">Post exposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference</span>, <span class="ref-journal">J. Infect. Dis.</span> (2006) <span class="ref-vol">193</span>:1650&#x02013;1657 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7110204/">PMC free article</a>]</span> [<a href="/pubmed/16703508" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Infect.+Dis.&amp;title=Post+exposure+protection+of+guinea+pigs+against+a+lethal+Ebola+virus+challenge+is+conferred+by+RNA+interference&amp;volume=193&amp;publication_year=2006&amp;pages=1650-1657&amp;pmid=16703508&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="mixed-citation">Gitlin L., Karelsky S., Andino R., <span class="ref-title">Short interfering RNA confers intracellular antiviral immunity in human cells</span>, <span class="ref-journal">Nature</span> (2002) <span class="ref-vol">418</span>:430&#x02013;434 [<a href="/pubmed/12087357" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Short+interfering+RNA+confers+intracellular+antiviral+immunity+in+human+cells&amp;volume=418&amp;publication_year=2002&amp;pages=430-434&amp;pmid=12087357&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="mixed-citation">Gitlin L., Andino R., <span class="ref-title">Nucleic acid-based immune system: the antiviral potential of mammalian RNA silencing</span>, <span class="ref-journal">J. Virol.</span> (2003) <span class="ref-vol">77</span>:7159&#x02013;7165 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC164787/">PMC free article</a>]</span> [<a href="/pubmed/12805414" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Virol.&amp;title=Nucleic+acid-based+immune+system:+the+antiviral+potential+of+mammalian+RNA+silencing&amp;volume=77&amp;publication_year=2003&amp;pages=7159-7165&amp;pmid=12805414&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="mixed-citation">Gray J., Fedorka-Cray P., Stabel T., Ackermann M., <span class="ref-title">Influence of inoculation route on the carrier state of <em>Salmonella choleraesuis</em> in swine</span>, <span class="ref-journal">Vet. Microbiol.</span> (1995) <span class="ref-vol">47</span>:43&#x02013;59 [<a href="/pubmed/8604554" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vet.+Microbiol.&amp;title=Influence+of+inoculation+route+on+the+carrier+state+of+Salmonella+choleraesuis+in+swine&amp;volume=47&amp;publication_year=1995&amp;pages=43-59&amp;pmid=8604554&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="mixed-citation">Grubman M.J., Baxt B., <span class="ref-title">Foot-and-mouth disease</span>, <span class="ref-journal">Clin. Microbiol. Rev.</span> (2004) <span class="ref-vol">17</span>:465&#x02013;493 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC387408/">PMC free article</a>]</span> [<a href="/pubmed/15084510" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin.+Microbiol.+Rev.&amp;title=Foot-and-mouth+disease&amp;volume=17&amp;publication_year=2004&amp;pages=465-493&amp;pmid=15084510&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="mixed-citation">Grubman M.J., de los Santos T., <span class="ref-title">Rapid control of foot-and-mouth disease outbreaks: is RNAi a possible solution?</span>, <span class="ref-journal">Trends Immunol.</span> (2005) <span class="ref-vol">26</span>:65&#x02013;68 [<a href="/pubmed/15668119" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Immunol.&amp;title=Rapid+control+of+foot-and-mouth+disease+outbreaks:+is+RNAi+a+possible+solution?&amp;volume=26&amp;publication_year=2005&amp;pages=65-68&amp;pmid=15668119&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="mixed-citation">Hohjoh H., <span class="ref-title">RNA interference (RNA (i)) induction with various types of synthetic oligonucleotide duplexes in cultured human cells</span>, <span class="ref-journal">FEBS Lett.</span> (2002) <span class="ref-vol">521</span>:195&#x02013;199 [<a href="/pubmed/12096714" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett.&amp;title=RNA+interference+(RNA+(i))+induction+with+various+types+of+synthetic+oligonucleotide+duplexes+in+cultured+human+cells&amp;volume=521&amp;publication_year=2002&amp;pages=195-199&amp;pmid=12096714&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="mixed-citation">Hohjoh H., <span class="ref-title">Enhancement of RNAi activity by improved siRNA duplexes</span>, <span class="ref-journal">FEBS Lett.</span> (2004) <span class="ref-vol">557</span>:193&#x02013;198 [<a href="/pubmed/14741366" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett.&amp;title=Enhancement+of+RNAi+activity+by+improved+siRNA+duplexes&amp;volume=557&amp;publication_year=2004&amp;pages=193-198&amp;pmid=14741366&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="mixed-citation">Holen T., Amarzguioui M., Wiiger M.T., Babaie E., Prydz H., <span class="ref-title">Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor</span>, <span class="ref-journal">Nucleic Acids Res.</span> (2002) <span class="ref-vol">30</span>:1757&#x02013;1766 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC113209/">PMC free article</a>]</span> [<a href="/pubmed/11937629" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res.&amp;title=Positional+effects+of+short+interfering+RNAs+targeting+the+human+coagulation+trigger+tissue+factor&amp;volume=30&amp;publication_year=2002&amp;pages=1757-1766&amp;pmid=11937629&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="mixed-citation">Kahana R., Kuznetzova L., Rogel A., Shemesh M., Hai D., Yadin H., Stram Y., <span class="ref-title">Inhibition of foot-and-mouth disease virus replication by small interfering RNA</span>, <span class="ref-journal">J. Gen. Virol.</span> (2004) <span class="ref-vol">85</span>:3213&#x02013;3217 [<a href="/pubmed/15483234" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Gen.+Virol.&amp;title=Inhibition+of+foot-and-mouth+disease+virus+replication+by+small+interfering+RNA&amp;volume=85&amp;publication_year=2004&amp;pages=3213-3217&amp;pmid=15483234&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="mixed-citation">Kim S., Lee K., Park J., Ko Y., Joo Y., Kim H., Park J., <span class="ref-title">Therapeutic application of RNA interference against foot-and-mouth disease virus in vitro and in vivo</span>, <span class="ref-journal">Antiviral. Res.</span> (2008) <span class="ref-vol">80</span>:178&#x02013;184 [<a href="/pubmed/18601955" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antiviral.+Res.&amp;title=Therapeutic+application+of+RNA+interference+against+foot-and-mouth+disease+virus+in+vitro+and+in+vivo&amp;volume=80&amp;publication_year=2008&amp;pages=178-184&amp;pmid=18601955&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="mixed-citation">King A.M., Underwood B.O., McCahon D., Newman J.W., Brown F., <span class="ref-title">Biochemical identification of viruses causing the 1981 outbreaks of foot-and-mouth disease in the UK</span>, <span class="ref-journal">Nature</span> (1981) <span class="ref-vol">293</span>:479&#x02013;480 [<a href="/pubmed/6273731" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Biochemical+identification+of+viruses+causing+the+1981+outbreaks+of+foot-and-mouth+disease+in+the+UK&amp;volume=293&amp;publication_year=1981&amp;pages=479-480&amp;pmid=6273731&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="mixed-citation">Li B.J., Tang Q., Cheng D., Qin C., Xie F.Y., Wei Q., et al., <span class="ref-title">Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque</span>, <span class="ref-journal">Nat. Med.</span> (2005) <span class="ref-vol">11</span>:944&#x02013;951 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7095788/">PMC free article</a>]</span> [<a href="/pubmed/16116432" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Med.&amp;title=Using+siRNA+in+prophylactic+and+therapeutic+regimens+against+SARS+coronavirus+in+Rhesus+macaque&amp;volume=11&amp;publication_year=2005&amp;pages=944-951&amp;pmid=16116432&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="mixed-citation">Liu M., Chen W., Ni Z., Yan W., Fei L., Jiao Y., et al., <span class="ref-title">Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome</span>, <span class="ref-journal">Virology</span> (2005) <span class="ref-vol">336</span>:51&#x02013;59 [<a href="/pubmed/15866070" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Cross-inhibition+to+heterologous+foot-and-mouth+disease+virus+infection+induced+by+RNA+interference+targeting+the+conserved+regions+of+viral+genome&amp;volume=336&amp;publication_year=2005&amp;pages=51-59&amp;pmid=15866070&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="mixed-citation">Liu M., Niu X., Yan J., Yan W., Zheng Z., <span class="ref-title">Immure response induced by oral DNA vaccination against FMDV delivered by attenuated <em>Salmonella choleraesuis</em> C500</span>, <span class="ref-journal">Front. Biol. China</span> (2006) <span class="ref-vol">2</span>:110&#x02013;114 <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front.+Biol.+China&amp;title=Immure+response+induced+by+oral+DNA+vaccination+against+FMDV+delivered+by+attenuated+Salmonella+choleraesuis+C500&amp;volume=2&amp;publication_year=2006&amp;pages=110-114&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="mixed-citation">Lu S., Cullen B.R., <span class="ref-title">Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and microRNA biogenesis</span>, <span class="ref-journal">J. Virol.</span> (2004) <span class="ref-vol">78</span>:12868&#x02013;12876 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC524998/">PMC free article</a>]</span> [<a href="/pubmed/15542639" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Virol.&amp;title=Adenovirus+VA1+noncoding+RNA+can+inhibit+small+interfering+RNA+and+microRNA+biogenesis&amp;volume=78&amp;publication_year=2004&amp;pages=12868-12876&amp;pmid=15542639&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="mixed-citation">Mason P.W., Piccone M.E., Mckenna T.S., Chinsangaram J., Grubman M.J., <span class="ref-title">Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate</span>, <span class="ref-journal">Virology</span> (1997) <span class="ref-vol">227</span>:96&#x02013;102 [<a href="/pubmed/9007062" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Evaluation+of+a+live-attenuated+foot-and-mouth+disease+virus+as+a+vaccine+candidate&amp;volume=227&amp;publication_year=1997&amp;pages=96-102&amp;pmid=9007062&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="mixed-citation">Mercado R., Vijh S., Allen S.E., Kerksiek K., Pilip I.M., Pamer E.G., <span class="ref-title">Early programming of T cell populations responding to bacterial infection</span>, <span class="ref-journal">J. Immunol.</span> (2000) <span class="ref-vol">165</span>:6833&#x02013;6839 [<a href="/pubmed/11120806" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Immunol.&amp;title=Early+programming+of+T+cell+populations+responding+to+bacterial+infection&amp;volume=165&amp;publication_year=2000&amp;pages=6833-6839&amp;pmid=11120806&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="mixed-citation">Mohapatra J.K., Sanyal A., Hemadri D., Tosh C., Kumar R.M., Bandyopadhyay S.K., <span class="ref-title">Evaluation of in vitro inhibitory potential of small interfering RNAs directed against various regions of foot-and-mouth disease virus genome</span>, <span class="ref-journal">Biochem. Biophys. Res. Commun.</span> (2005) <span class="ref-vol">329</span>:1133&#x02013;1138 [<a href="/pubmed/15752771" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.+Biophys.+Res.+Commun.&amp;title=Evaluation+of+in+vitro+inhibitory+potential+of+small+interfering+RNAs+directed+against+various+regions+of+foot-and-mouth+disease+virus+genome&amp;volume=329&amp;publication_year=2005&amp;pages=1133-1138&amp;pmid=15752771&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="mixed-citation">O&#x02019;Reilly E.K., Kao C.C., <span class="ref-title">Analysis of RNA-dependent RNA polymerase structure and function as guided by known polymerase structures and computer predictions of secondary structure</span>, <span class="ref-journal">Virology</span> (1998) <span class="ref-vol">252</span>:287&#x02013;303 [<a href="/pubmed/9878607" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Analysis+of+RNA-dependent+RNA+polymerase+structure+and+function+as+guided+by+known+polymerase+structures+and+computer+predictions+of+secondary+structure&amp;volume=252&amp;publication_year=1998&amp;pages=287-303&amp;pmid=9878607&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">35. <span class="mixed-citation">Paglia P., Medina E., Arioli I., Guzman C.A., Colombo M.P., <span class="ref-title">Gene transfer in dendritic cells induced by oral DNA vaccination with <em>Salmonella typhimurium</em> results in protective immunity against a murine fibrosarcoma</span>, <span class="ref-journal">Blood</span> (1998) <span class="ref-vol">92</span>:3172&#x02013;3176 [<a href="/pubmed/9787153" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Gene+transfer+in+dendritic+cells+induced+by+oral+DNA+vaccination+with+Salmonella+typhimurium+results+in+protective+immunity+against+a+murine+fibrosarcoma&amp;volume=92&amp;publication_year=1998&amp;pages=3172-3176&amp;pmid=9787153&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R36">36. <span class="mixed-citation">Pereira H.G., <span class="ref-title">Foot-and-mouth disease</span>, in: Gibbs E.P.J. (Ed.), <span class="ref-journal">Virus diseases of food animals</span>, Academic Press, Inc., San Diego, California, 1981, pp. 333&#x02013;363 <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Virus+diseases+of+food+animals&amp;publication_year=1981&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R37">37. <span class="mixed-citation">Prato Murphy M.L., Meyer R.F., Mebus C., Schudel A.A., Rodriguez M., <span class="ref-title">Analysis of sites of FMDV persistence in carrier cattle via the polymerase chain reaction</span>, <span class="ref-journal">Arch. Virol.</span> (1994) <span class="ref-vol">136</span>:299&#x02013;307 [<a href="/pubmed/8031235" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch.+Virol.&amp;title=Analysis+of+sites+of+FMDV+persistence+in+carrier+cattle+via+the+polymerase+chain+reaction&amp;volume=136&amp;publication_year=1994&amp;pages=299-307&amp;pmid=8031235&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R38">38. <span class="mixed-citation">Reed L.J., Muench H.A., <span class="ref-title">A simple method of estimating fifty percent end points</span>, <span class="ref-journal">Am. J. Hyg.</span> (1938) <span class="ref-vol">27</span>:493&#x02013;497 <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am.+J.+Hyg.&amp;title=A+simple+method+of+estimating+fifty+percent+end+points&amp;volume=27&amp;publication_year=1938&amp;pages=493-497&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R39">39. <span class="mixed-citation">Rigden R.C., Carrasco C.P., Barnett P.V., Summerfield A., McCullough K.C., <span class="ref-title">Innate immune responses following emergency vaccination against foot-and-mouth disease virus in pigs</span>, <span class="ref-journal">Vaccine</span> (2003) <span class="ref-vol">21</span>:1466&#x02013;1477 [<a href="/pubmed/12615443" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Innate+immune+responses+following+emergency+vaccination+against+foot-and-mouth+disease+virus+in+pigs&amp;volume=21&amp;publication_year=2003&amp;pages=1466-1477&amp;pmid=12615443&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R40">40. <span class="mixed-citation">Shen C., Buck A.K., Liu X., Winkler M., Reske S.N., <span class="ref-title">Gene silencing by adenovirus-delivered siRNA</span>, <span class="ref-journal">FEBS Lett.</span> (2003) <span class="ref-vol">539</span>:111&#x02013;114 [<a href="/pubmed/12650936" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett.&amp;title=Gene+silencing+by+adenovirus-delivered+siRNA&amp;volume=539&amp;publication_year=2003&amp;pages=111-114&amp;pmid=12650936&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R41">41. <span class="mixed-citation">Shiau A.L., Chen Y.L., Liao C.Y., Huang Y.S., Wu C.L., <span class="ref-title">Prothymosin enhances protective immune responses induced by oral DNA vaccination against pseudorabies delivered by <em>Salmonella choleraesuis</em></span>, <span class="ref-journal">Vaccine</span> (2001) <span class="ref-vol">19</span>:3947&#x02013;3956 [<a href="/pubmed/11427270" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Prothymosin+enhances+protective+immune+responses+induced+by+oral+DNA+vaccination+against+pseudorabies+delivered+by+Salmonella+choleraesuis&amp;volume=19&amp;publication_year=2001&amp;pages=3947-3956&amp;pmid=11427270&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R42">42. <span class="mixed-citation">Song E., Lee S.K., Dykxhoorn D.M., Novina C., Zhang D., Crawford K., et al., <span class="ref-title">Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages</span>, <span class="ref-journal">J. Virol.</span> (2003) <span class="ref-vol">77</span>:7174&#x02013;7181 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC164789/">PMC free article</a>]</span> [<a href="/pubmed/12805416" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Virol.&amp;title=Sustained+small+interfering+RNA-mediated+human+immunodeficiency+virus+type+1+inhibition+in+primary+macrophages&amp;volume=77&amp;publication_year=2003&amp;pages=7174-7181&amp;pmid=12805416&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R43">43. <span class="mixed-citation">Srinivasan A., Foley J., Ravindran R., McSorley S.J., <span class="ref-title">Low-dose <em>Salmonella</em> infection evades activation of flagellin-specific CD4 T cells</span>, <span class="ref-journal">J. Immunol.</span> (2004) <span class="ref-vol">173</span>:4091&#x02013;4099 [<a href="/pubmed/15356159" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Immunol.&amp;title=Low-dose+Salmonella+infection+evades+activation+of+flagellin-specific+CD4+T+cells&amp;volume=173&amp;publication_year=2004&amp;pages=4091-4099&amp;pmid=15356159&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R44">44. <span class="mixed-citation">Steitz T.A., <span class="ref-title">A mechanism for all polymerases</span>, <span class="ref-journal">Nature</span> (1998) <span class="ref-vol">391</span>:231&#x02013;232 [<a href="/pubmed/9440683" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A+mechanism+for+all+polymerases&amp;volume=391&amp;publication_year=1998&amp;pages=231-232&amp;pmid=9440683&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R45">45. <span class="mixed-citation">Sun T., Lu P., Wang X., <span class="ref-title">Localization of infection-related epitopes on the nonstructural protein 3ABC of foot-and-mouth disease virus and the application of tandem epitopes</span>, <span class="ref-journal">J. Virol. Methods</span> (2004) <span class="ref-vol">119</span>:79&#x02013;86 [<a href="/pubmed/15158588" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Virol.+Methods&amp;title=Localization+of+infection-related+epitopes+on+the+nonstructural+protein+3ABC+of+foot-and-mouth+disease+virus+and+the+application+of+tandem+epitopes&amp;volume=119&amp;publication_year=2004&amp;pages=79-86&amp;pmid=15158588&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R46">46. <span class="mixed-citation">Ter Brake O., Konstantinova P., Ceylan M., Berkhout B., <span class="ref-title">Silencing of HIV-1 with RNA interference: a multiple shRNA approach</span>, <span class="ref-journal">Mol. Ther.</span> (2006) <span class="ref-vol">14</span>:883&#x02013;892 [<a href="/pubmed/16959541" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol.+Ther.&amp;title=Silencing+of+HIV-1+with+RNA+interference:+a+multiple+shRNA+approach&amp;volume=14&amp;publication_year=2006&amp;pages=883-892&amp;pmid=16959541&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R47">47. <span class="mixed-citation">Woo P., Wong L., Zheng B., Yuen K., <span class="ref-title">Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated <em>Salmonella typhimurium</em></span>, <span class="ref-journal">Vaccine</span> (2001) <span class="ref-vol">19</span>:2945&#x02013;2954 [<a href="/pubmed/11282206" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Unique+immunogenicity+of+hepatitis+B+virus+DNA+vaccine+presented+by+live-attenuated+Salmonella+typhimurium&amp;volume=19&amp;publication_year=2001&amp;pages=2945-2954&amp;pmid=11282206&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R48">48. <span class="mixed-citation">Zhao L.J., Jian H., Zhu H., <span class="ref-title">Specific gene inhibition by adenovirus-mediated expression of small interfering RNA</span>, <span class="ref-journal">Gene</span> (2003) <span class="ref-vol">316</span>:137&#x02013;141 [<a href="/pubmed/14563560" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gene&amp;title=Specific+gene+inhibition+by+adenovirus-mediated+expression+of+small+interfering+RNA&amp;volume=316&amp;publication_year=2003&amp;pages=137-141&amp;pmid=14563560&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R49">49. <span class="mixed-citation">Zimmermann T.S., Lee A.C.H., Akinc A., Bramlage B., Bumcrot D., Fedoruk M.N., et al., <span class="ref-title">RNAi-mediated gene silencing in non-human primates</span>, <span class="ref-journal">Nature</span> (2006) <span class="ref-vol">441</span>:111&#x02013;114 [<a href="/pubmed/16565705" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=RNAi-mediated+gene+silencing+in+non-human+primates&amp;volume=441&amp;publication_year=2006&amp;pages=111-114&amp;pmid=16565705&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2826090&amp;issue-id=184828&amp;journal-id=892&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">Veterinary Research</span> are provided here courtesy of <strong>BioMed Central</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2826090/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2826090/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2826090/pdf/vetres-41-30.pdf">PDF (430K)</a></li> | <li><a href="#" data-citationid="PMC2826090" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2826090%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2826090%2F&amp;text=Attenuated%20Salmonella%20choleraesuis-mediated%20RNAi%20targeted%20to%20conserved%20regions%20against%20foot-and-mouth%20disease%20virus%20in%20guinea%20pigs%20and%20swine"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2826090%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="20167192" data-aiid="2826090" data-aid="2826090" data-iid="184828" data-domainid="892" data-domain="vetres" data-accid="PMC2826090" data-md5="8b7c08f0e2358e590464c897a9dfe285"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T20:32:45-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1BEBFCE9A484F100000000017D017D&amp;ncbi_session=8A1BEBFCE9A4AAC1_0381SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2826090%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=vetres&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2826090/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1BEBFCE9A4AAC1_0381SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'